Literature DB >> 24553982

Echocardiographic parameters and survival in Chagas heart disease with severe systolic dysfunction.

Daniela do Carmo Rassi1, Marcelo Luiz Campos Vieira2, Ana Lúcia Martins Arruda3, Viviane Tiemi Hotta2, Rogério Gomes Furtado1, Danilo Teixeira Rassi1, Salvador Rassi1.   

Abstract

BACKGROUND: Echocardiography provides important information on the cardiac evaluation of patients with heart failure. The identification of echocardiographic parameters in severe Chagas heart disease would help implement treatment and assess prognosis.
OBJECTIVE: To correlate echocardiographic parameters with the endpoint cardiovascular mortality in patients with ejection fraction < 35%.
METHODS: Study with retrospective analysis of pre-specified echocardiographic parameters prospectively collected from 60 patients included in the Multicenter Randomized Trial of Cell Therapy in Patients with Heart Diseases (Estudo Multicêntrico Randomizado de Terapia Celular em Cardiopatias) - Chagas heart disease arm. The following parameters were collected: left ventricular systolic and diastolic diameters and volumes; ejection fraction; left atrial diameter; left atrial volume; indexed left atrial volume; systolic pulmonary artery pressure; integral of the aortic flow velocity; myocardial performance index; rate of increase of left ventricular pressure; isovolumic relaxation time; E, A, Em, Am and Sm wave velocities; E wave deceleration time; E/A and E/Em ratios; and mitral regurgitation.
RESULTS: In the mean 24.18-month follow-up, 27 patients died. The mean ejection fraction was 26.6 ± 5.34%. In the multivariate analysis, the parameters ejection fraction (HR = 1.114; p = 0.3704), indexed left atrial volume (HR = 1.033; p < 0.0001) and E/Em ratio (HR = 0.95; p = 0.1261) were excluded. The indexed left atrial volume was an independent predictor in relation to the endpoint, and values > 70.71 mL/m2 were associated with a significant increase in mortality (log rank p < 0.0001).
CONCLUSION: The indexed left atrial volume was the only independent predictor of mortality in this population of Chagasic patients with severe systolic dysfunction.

Entities:  

Mesh:

Year:  2014        PMID: 24553982      PMCID: PMC3987318          DOI: 10.5935/abc.20140003

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  19 in total

1.  Prognostic value of QT interval parameters for mortality risk stratification in Chagas' disease: results of a long-term follow-up study.

Authors:  Gil Salles; Sergio Xavier; Andrea Sousa; Alejandro Hasslocher-Moreno; Claudia Cardoso
Journal:  Circulation       Date:  2003-06-30       Impact factor: 29.690

2.  Chagas' disease; a clinical, epidemiologic, and pathologic study.

Authors:  E DIAS; F S LARANJA; A MIRANDA; G NOBREGA
Journal:  Circulation       Date:  1956-12       Impact factor: 29.690

3.  Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community.

Authors:  J H Maguire; R Hoff; I Sherlock; A C Guimarães; A C Sleigh; N B Ramos; K E Mott; T H Weller
Journal:  Circulation       Date:  1987-06       Impact factor: 29.690

4.  Chagas' heart disease: evolutive evaluation of electrocardiographic and echocardiographic parameters in patients with the indeterminate form.

Authors:  B M Ianni; E Arteaga; C C Frimm ; A C Pereira Barretto; C Mady
Journal:  Arq Bras Cardiol       Date:  2001-07       Impact factor: 2.000

5.  Cell therapy in Chagas cardiomyopathy (Chagas arm of the multicenter randomized trial of cell therapy in cardiopathies study): a multicenter randomized trial.

Authors:  Ricardo Ribeiro Dos Santos; Salvador Rassi; Gilson Feitosa; Oswaldo T Grecco; Anis Rassi; Ademir B da Cunha; Valéria B de Carvalho; Luiz César Guarita-Souza; Wilson de Oliveira; Bernardo R Tura; Milena B P Soares; Antonio C Campos de Carvalho
Journal:  Circulation       Date:  2012-04-20       Impact factor: 29.690

6.  Noninvasive predictors of mortality for patients with Chagas' heart disease: a multivariate stepwise logistic regression study.

Authors:  R B Bestetti; C M Dalbo; O C Freitas; L A Teno; O T Castilho; J S Oliveira
Journal:  Cardiology       Date:  1994       Impact factor: 1.869

7.  Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure.

Authors:  R J Viotti; C Vigliano; S Laucella; B Lococo; M Petti; G Bertocchi; B Ruiz Vera; H Armenti
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

8.  Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy.

Authors:  C Mady; R H Cardoso; A C Barretto; P L da Luz; G Bellotti; F Pileggi
Journal:  Circulation       Date:  1994-12       Impact factor: 29.690

9.  [Segmental changes in contractility of the left heart ventricle in Chagas cardiomyopathy with and without ventricular dilatation].

Authors:  E J Câmara
Journal:  Arq Bras Cardiol       Date:  1993-03       Impact factor: 2.000

10.  [Assessment of diastolic function in Chagas' disease with pulsed doppler tissue imaging].

Authors:  Ricardo A Migliore; María E Adaniya; Horacio Tamagusuku; Alberto Lapuente
Journal:  Arch Cardiol Mex       Date:  2004 Jan-Mar
View more
  5 in total

1.  Prognostic Factors in Severe Chagasic Heart Failure.

Authors:  Sandra de Araújo Costa; Salvador Rassi; Elis Marra da Madeira Freitas; Natália da Silva Gutierrez; Fabiana Miranda Boaventura; Larissa Pereira da Costa Sampaio; João Bastista Masson Silva
Journal:  Arq Bras Cardiol       Date:  2017-03       Impact factor: 2.000

2.  Cardiovascular Biomarkers and Diastolic Dysfunction in Patients With Chronic Chagas Cardiomyopathy.

Authors:  Luis E Echeverría; Sergio Alejandro Gómez-Ochoa; Lyda Z Rojas; Karen Andrea García-Rueda; Pedro López-Aldana; Taulant Muka; Carlos A Morillo
Journal:  Front Cardiovasc Med       Date:  2021-11-29

Review 3.  Longitudinal Speckle Tracking Strain Abnormalities in Chagas Disease: A Systematic Review and Meta-Analysis.

Authors:  Sergio Alejandro Gómez-Ochoa; Lyda Z Rojas; Juliana Alexandra Hernández-Vargas; Jorge Largo; Taulant Muka; Luis E Echeverría
Journal:  J Clin Med       Date:  2022-01-31       Impact factor: 4.241

4.  Biomarkers and mortality in severe Chagas cardiomyopathy.

Authors:  Jacqueline E Sherbuk; Emi E Okamoto; Morgan A Marks; Enzo Fortuny; Eva H Clark; Gerson Galdos-Cardenas; Angel Vasquez-Villar; Antonio B Fernandez; Thomas C Crawford; Rose Q Do; Jorge Luis Flores-Franco; Rony Colanzi; Robert H Gilman; Caryn Bern
Journal:  Glob Heart       Date:  2015-09

5.  Prevalence and determinants of depressive symptoms in patients with Chagas cardiomyopathy and predominantly preserved cardiac function.

Authors:  Whesley Tanor Silva; Matheus Ribeiro Ávila; Lucas Frois Fernandes de Oliveira; Pedro Henrique Scheidt Figueiredo; Vanessa Pereira Lima; Alessandra de Carvalho Bastone; Fábio Silva Martins da Costa; Mauro Felippe Felix Mediano; Henrique Silveira Costa; Manoel Otávio da Costa Rocha
Journal:  Rev Soc Bras Med Trop       Date:  2020-11-06       Impact factor: 1.581

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.